Publication date: Available online 6 August 2020Source: Clinical NeurophysiologyAuthor(s): Annacarmen NILO, Arielle CRESPEL, Pierre GENTON, Greta MACORIG, Gian Luigi GIGLI, Philippe GELISSE
Publication date: Available online 6 August 2020Source: Clinical NeurophysiologyAuthor(s): Mihai Moldovan, Chiara Pisciotta, Davide Pareyson, Christian Krarup
Impaired cortical beta-band modulation presages innovation of neuromodulation in Parkinson’s disease
Publication date: Available online 6 August 2020Source: Clinical NeurophysiologyAuthor(s): Hiroatsu Murakami, Masako Kinoshita
Publication date: Available online 6 August 2020Source: Clinical NeurophysiologyAuthor(s): V Rizzo, C. Mastroeni, R. Maggio, C. Terranova, P. Girlanda, H.R. Siebner, A. Quartarone
Publication date: Available online 6 August 2020Source: Clinical NeurophysiologyAuthor(s): Elia Valentini, Enrico Schulz
Publication date: Available online 6 August 2020Source: Clinical NeurophysiologyAuthor(s): Tejaswi Kandula, Susanna B. Park, Kate A. Carey, Cindy S-Y. Lin, Michelle A. Farrar
Mark above section as read
Abstract A prenylated flavonoid, cudraflavanone B, is isolated from Cudrania tricuspidata. In this study, we investigated its anti-inflammatory and anti-neuroinflammatory effects in lipopolysaccharide (LPS)-induced RAW264.7 and BV2 cells. In our initial study of the anti-inflammatory effects of cudraflavanone B the production of nitric oxide and prostaglandin E2 was attenuated in LPS-stimulated RAW264.7 and BV2 cells. These inhibitory...
Mark above section as read
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου